Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

Epigenetic silencing of maspin gene expression in human breast cancers.

Domann FE, Rice JC, Hendrix MJ, Futscher BW.

Int J Cancer. 2000 Mar 15;85(6):805-10.

2.

Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.

Boltze C, Schneider-Stock R, Quednow C, Hinze R, Mawrin C, Hribaschek A, Roessner A, Hoang-Vu C.

Int J Mol Med. 2003 Oct;12(4):479-84.

PMID:
12964023
3.

Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer.

Maass N, Biallek M, Rösel F, Schem C, Ohike N, Zhang M, Jonat W, Nagasaki K.

Biochem Biophys Res Commun. 2002 Sep 13;297(1):125-8.

PMID:
12220518
4.

Epigenetic regulation of maspin expression in human ovarian carcinoma cells.

Rose SL, Fitzgerald MP, White NO, Hitchler MJ, Futscher BW, De Geest K, Domann FE.

Gynecol Oncol. 2006 Aug;102(2):319-24. Epub 2006 Feb 7.

PMID:
16457875
5.

Aberrant methylation of the maspin promoter is an early event in human breast cancer.

Futscher BW, O'Meara MM, Kim CJ, Rennels MA, Lu D, Gruman LM, Seftor RE, Hendrix MJ, Domann FE.

Neoplasia. 2004 Jul-Aug;6(4):380-9.

6.

Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.

Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.

Breast Cancer Res. 2008;10(5):R82. doi: 10.1186/bcr2151. Epub 2008 Sep 30.

7.
8.

DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.

Roll JD, Rivenbark AG, Jones WD, Coleman WB.

Mol Cancer. 2008 Jan 25;7:15. doi: 10.1186/1476-4598-7-15.

9.

Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.

Virmani A, Rathi A, Sugio K, Sathyanarayana UG, Toyooka S, Kischel FC, Tonk V, Padar A, Takahashi T, Roth JA, Euhus DM, Minna JD, Gazdar AF.

Int J Cancer. 2003 Aug 20;106(2):198-204.

10.

Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.

Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF.

Cancer Res. 2001 Jun 1;61(11):4556-60.

11.

TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers.

Conway KE, McConnell BB, Bowring CE, Donald CD, Warren ST, Vertino PM.

Cancer Res. 2000 Nov 15;60(22):6236-42.

12.

Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.

Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y.

Cancer Res. 2003 Jul 15;63(14):4174-80.

13.

Epigenetic status and aberrant expression of the maspin gene in human hepato-biliary tract carcinomas.

Fujisawa K, Maesawa C, Sato R, Wada K, Ogasawara S, Akiyama Y, Takeda M, Fujita T, Otsuka K, Higuchi T, Suzuki K, Saito K, Masuda T.

Lab Invest. 2005 Feb;85(2):214-24.

14.

Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling.

Sato N, Fukushima N, Matsubayashi H, Goggins M.

Oncogene. 2004 Feb 26;23(8):1531-8.

PMID:
14716296
15.

Aberrant maspin expression in human endometrial cancer.

Murai S, Maesawa C, Masuda T, Sugiyama T.

Cancer Sci. 2006 Sep;97(9):883-8. Epub 2006 Jul 4.

16.

Role for DNA methylation in the control of cell type specific maspin expression.

Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H, Domann FE.

Nat Genet. 2002 Jun;31(2):175-9. Epub 2002 May 20.

PMID:
12021783
17.

Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.

Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF.

Clin Cancer Res. 2003 Dec 15;9(17):6389-94.

18.

Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.

Tang D, Sivko GS, DeWille JW.

Breast Cancer Res Treat. 2006 Jan;95(2):161-70. Epub 2005 Dec 2.

PMID:
16322893
19.
20.

SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.

Dallol A, Da Silva NF, Viacava P, Minna JD, Bieche I, Maher ER, Latif F.

Cancer Res. 2002 Oct 15;62(20):5874-80.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk